Valuation: Camurus AB

Market Cap 37.19B 3.71B 3.28B 3.1B 2.81B 5.27B 356B 5.32B 14.33B 182B 13.94B 13.64B 585B P/E 2026 *
38.1x
P/E 2027 * 27.1x
Enterprise Value 32.68B 3.26B 2.88B 2.72B 2.47B 4.63B 313B 4.68B 12.59B 160B 12.25B 11.98B 514B EV / Sales 2026 *
11.4x
EV / Sales 2027 * 8.37x
Free-Float
66.89%
Yield 2026 *
-
Yield 2027 * -
1 day-0.87%
1 week-0.24%
Current month+7.11%
1 month+4.08%
3 months+12.71%
6 months+38.89%
Current year+1.46%
1 week 613
Extreme 613
641.5
1 month 571.5
Extreme 571.5
641.5
Current year 430.8
Extreme 430.8
710
1 year 430.8
Extreme 430.8
710
3 years 299.8
Extreme 299.8
754.5
5 years 120
Extreme 120
754.5
10 years 58
Extreme 58
754.5
Manager TitleAgeSince
Chief Executive Officer 63 01/01/2003
Director of Finance/CFO 57 01/07/2025
Chief Tech/Sci/R&D Officer 58 01/01/2025
Director TitleAgeSince
Director/Board Member 63 01/01/2002
Chairman 77 01/01/2015
Director/Board Member 61 07/05/2020
Date Insider Type Main position Quantity % Market Cap. Importance
07/08/26 Sell

Executive/Senior Manager

-5,800 0.0096%
27/02/26 Sell

Chief Executive Officer

55,550 0.0928%
27/02/26 Sell

Chief Executive Officer

1,500 0.0025%
Change 5-day change 1-year change 3-year change Capi.($)
-0.87%-0.24%-6.79%+101.09% 3.77B
-0.01%+1.24%+63.06%+120.55% 1,056B
-1.61%-0.60%+47.32%+71.79% 655B
-1.12%-0.72%+17.98%+76.63% 471B
-1.72%-4.06%+36.39%+39.47% 342B
-0.40%+3.83%+22.08%+28.82% 277B
-0.51%-1.93%+12.09%+11.94% 257B
+1.32%+3.27%+54.63%+57.63% 226B
-0.61%-0.91%+34.33%+101.87% 189B
-0.24%-2.76%-28.41%-60.92% 170B
Average -0.26%+0.99%+25.27%+54.89% 364.67B
Weighted average by Cap. -0.05%+0.81%+38.87%+70.55%

Financials

2026 *2027 *
Net sales 2.86B 285M 252M 238M 216M 405M 27.37B 409M 1.1B 13.97B 1.07B 1.05B 44.97B 3.75B 374M 330M 312M 283M 531M 35.9B 536M 1.44B 18.33B 1.4B 1.37B 59B
Net income 978M 97.61M 86.14M 81.5M 73.91M 139M 9.37B 140M 377M 4.78B 367M 359M 15.39B 1.37B 137M 121M 114M 104M 194M 13.14B 196M 529M 6.71B 514M 503M 21.6B
Net Debt -4.52B -451M -398M -377M -341M -640M -43.27B -647M -1.74B -22.1B -1.69B -1.66B -71.11B -5.81B -580M -512M -484M -439M -823M -55.63B -831M -2.24B -28.41B -2.18B -2.13B -91.42B
Logo Camurus AB
Camurus AB is a Sweden-based research and development based pharmaceutical and biotechnology company with a focus on the development and marketing of specialty medicines, providing patients suffering from severe and chronic disease, such as opioid dependence, pain, cancer, and endocrine diseases. The Company has a diversified research portfolio, which includes products in clinical trials. The Company’s products are based on FluidCrystal formulation technology. FluidCrystal is Company's patent-protected technology platform. Camurus AB is the parent company of the Group, which comprises of legal entities, namely: Camurus Inc, Cubosome Inc, Development AB, Camurus GmbH, Camurus Ltd, Camurus Oy, Camurus AS, Camurus SAS, Camurus Pty Ltd, Camurus S.L, Camurus ApS, Camurus BV and Camurus Austria GmbH.
Employees
316
Date Price Change Volume
29/09/26 SEK 625.00 -0.87% 75,287
28/09/26 SEK 630.50 +2.35% 94,106
25/09/26 SEK 616.00 0.00% 80,403
24/09/26 SEK 616.00 -1.36% 67,164
23/09/26 SEK 624.50 -0.32% 56,852
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
625.00SEK
Average target price
793.00SEK
Spread / Average Target
+26.88%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CAMX Stock